Skip to content

This Site is Intended for Healthcare Professionals Only

Search AI Powered

Latest Stories

Steve Barclay to work with community pharmacists to 'tackle barriers' to offering more services

The Secretary of State for Health and Social Care Steve Barclay has expressed his interest to work with ‘community pharmacists in tackling barriers to offer more services’ from the sector.

Community pharmacists can support with many more things to ease pressure on general practice, Barclay told parliament while he was updating on ‘what the government is doing to help the NHS deal with immediate winter pressures on Monday (9 January).


He further updated that from the end of March community pharmacies will take referrals from ‘Urgent and Emergency Care’ settings.

He added: “Later this year we will also start offering oral contraceptive services, including how we better use digital services.”

The service was originally planned to commence on 11th January 2023 and was delayed to ‘early 2023’.

“The primary care recovery plan will set out a range of additional services pharmacists can deliver,” Barclay said.

Responding to his statement, the Pharmaceutical Services Negotiating Committee (PSNC) commented: “We were pleased to hear the Secretary of State talking so positively and hope he is convinced of the case for investment in community pharmacies so that they can do more to help the NHS and the public it serves at this very difficult time.”

It added: “PSNC has aways believed that with greater integration, capacity and sustainable funding, community pharmacy can be a key part of the solution for big NHS challenges such as GP access.”

“It was good to hear the Secretary of State recognising that along with all the wider value that pharmacies deliver.”

The committee has been discussing a fully funded Pharmacy First scheme with the Government for many months – “putting a business case forward for this in our CPCF negotiations last Spring. We remain ready to start negotiations on this as soon as they want to.”

“As we said in our recent letter to the Secretary of State, the Government is now at a fork in the road – it must decide whether it wants that sustainable, fully resourced community pharmacy sector which could continue to deliver huge value to patients while also doing more to ease wider NHS pressures; or does it want to continue to degrade our sector and the services that so many people rely on. We very much hope the Secretary of State agrees it must be the former, and that Government is ready to back this with appropriate funding.”

On Saturday (7 January), the Association of Independent Multiple Pharmacies (AIMp) board director and member and also the executive director of Day Lewis, Jay Patel highlighted the key issues and on ground challenges faced by the community pharmacy at the ‘pan- healthcare roundtable' discussions hosted by Prime Minister Rishi Sunak and the health secretary in Downing Street.

Dr Leyla Hannbeck, chief executive AIMp said: “We welcome the announcement by Secretary of State for health and social care Steve Barclays on 9 January eluding to government’s desire to progress a Pharmacy First scheme for England.”

“Pharmacy First scheme has historically presented a challenge for negotiators to land in recent years. It is clear barriers have existed to the notion of efficacious products being available readily through the pharmacy network - we hope that this is now fast tracked underpinned by a willingness to happen in the light of huge capacity challenges facing the NHS.”

The association hopes that Pharmacy First becomes the catalyst to future pathways delivered by community pharmacy in order to improve patients access to care - for example a vaccination first scheme as part of the prevention agenda, and integration to management of long term conditions.

More For You

Chemotherapy-free leukaemia treatment

The trial found that a combination of two cancer drugs, ibrutinib and venetoclax, could perform better than chemotherapy among patients with chronic lymphocytic leukaemia.

iStock

Chemotherapy-free leukaemia treatment shows promise during trial

In a breakthrough in leukaemia research, scientists in the UK have tested a chemotherapy-free approach, involving a combination of targeted drugs, which may offer better outcomes.

The new treatment could radically change the way chronic lymphocytic leukaemia (CLL), the most common form of leukaemia in adults, is treated.

Keep ReadingShow less
Locum pharmacists in the UK work in a difficult environment, and many are dissatisfied with their jobs.

Locum pharmacists in the UK work in a difficult environment, and many are dissatisfied with their jobs.

iStock

Locums should stand up for their interests, say 'no' to unfair terms: PDA

The Pharmacists' Defence Association (PDA) has advised locum pharmacists to be vigilant about their interests and negotiate directly with their businesses, avoid working with digital platforms driven by algorithms, and be aware of regressive contract terms.

The not-for-profit organisation issued such an advisory following its survey of 1,300 UK locum pharmacists, which showed that they work in a difficult environment and that most are dissatisfied with their jobs.

Keep ReadingShow less
Wales ranked worst for second-trimester abortion access in the UK

Each year about 175 women travel from Wales to England for care

Wales ranked worst for second-trimester abortion access in the UK

A leading healthcare charity has revealed that Wales is the worst part of the United Kingdom for allowing surgical abortions for women.

Surgical abortion is the process removing pregnancy from the womb by inducing local anaesthesia, conscious sedation or general anaesthesia.

Keep ReadingShow less
The fund offers £150 per eligible child - for up to three children per household.

The fund offers £150 per eligible child - for up to three children per household.

Charity reopens funding to ease back to school financial pressures for community pharmacists

Community pharmacists struggling with the costs of their children going back to school can apply for funding from The Leverhulme Trade Charities Trust (LTCT)

The Trust is providing up to £100,000 of support to those working in a community pharmacy or are a registered pharmacist or pharmacy technician

Keep ReadingShow less
Germany's BioNTech to buy CureVac to boost cancer research

Both biotech companies have been working for years in the area of mRNA vaccines and treatments

Germany's BioNTech to buy CureVac to boost cancer research

Germany's BioNTech is buying domestic rival CureVac for $1.25 billion, bringing together two pharmaceutical firms specialised in mRNA technology with the goal of advancing cancer treatments.

BioNTech, which developed the first coronavirus vaccine to be approved in the West along with US pharmaceutical giant Pfizer, said the acquisition would "bring together complementary capabilities and leverage technologies".

Keep ReadingShow less